c-MYC and cyclin D1 are two major oncogenes, which confer proliferative and anti-apoptosis capacities to breast cancer cells [15], and are associated with altered sensitivity to endocrine therapy [24]. The gene discussed is MYC; the disease is breast carcinoma.